Back to company

Scanbio Denmark ApS: Financial statements 2023

CVR: 42107654

Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 11,150,985 and a net result of DKK 4,013,557 compared with DKK 3,884,563 the year before. That is an increase of 38.3% compared with the year before. Equity amounted to DKK 8,385,802. The solvency ratio was 33.7%. The company had 4 employees in the financial year.

Gross Profit
11,150,985 kr.
Profit/Loss
4,013,557 kr.
Equity
8,385,802 kr.
Total Assets
24,907,567 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-11.2 mio.4 mio.8.4 mio.4
2022-8.1 mio.3.9 mio.4.4 mio.4
2021-2.5 mio.448 t.488 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Scanbio Denmark ApS: The 2022 annual report is outAug 7, 2023

Scanbio Denmark ApS has published its annual report for 2022. Gross profit came to DKK 8,062,158, and the net result was DKK 3,884,563.

About Scanbio Denmark ApS

Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity amounted to DKK 10,249,140.

Other financial years